Autolus Therapeutics plc
AUTL
$1.57
$0.1611.35%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 29.00K | -- | -- | 10.09M | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.00K | -- | -- | 10.09M | 0.00 |
| Cost of Revenue | 138.30M | 1.22M | 36.61M | 30.67M | 117.33M |
| Gross Profit | -138.28M | -1.22M | -36.61M | -20.58M | -117.33M |
| SG&A Expenses | 42.48M | 27.33M | 21.90M | 18.18M | 23.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.89M | 67.65M | 58.52M | 48.85M | 53.27M |
| Operating Income | -75.86M | -67.65M | -58.52M | -38.76M | -53.27M |
| Income Before Tax | -26.14M | -82.07M | -58.22M | -52.70M | -77.20M |
| Income Tax Expenses | 1.46M | 22.00K | 51.00K | -8.00K | -24.00K |
| Earnings from Continuing Operations | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M |
| EBIT | -75.86M | -67.65M | -58.52M | -38.76M | -53.27M |
| EBITDA | -73.79M | -65.72M | -56.62M | -36.95M | -51.50M |
| EPS Basic | -0.10 | -0.31 | -0.22 | -0.24 | -0.44 |
| Normalized Basic EPS | -0.06 | -0.19 | -0.14 | -0.15 | -0.28 |
| EPS Diluted | -0.10 | -0.31 | -0.22 | -0.24 | -0.44 |
| Normalized Diluted EPS | -0.06 | -0.19 | -0.14 | -0.15 | -0.28 |
| Average Basic Shares Outstanding | 266.20M | 266.08M | 266.03M | 222.17M | 174.10M |
| Average Diluted Shares Outstanding | 266.20M | 266.08M | 266.03M | 222.17M | 174.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
